Wikipedia -WSS

Wikipedia

author：leisure time 2025-10-02 19:20:25 - browse：6611

Christopher Boerner -- biotech JPM coverage from STAT — Bristol CEO Christopher Boerner Business Wire via AP

SAN FRANCISCO — Christopher Boerner has been the CEO of Bristol Myers Squibb for just two months. But in trying to sell the company to investors on Monday at the annual J.P. Morgan Healthcare Conference, he pointed to the company’s 150-year history.

He spoke of the “next chapter” for BMS, which saw its stock fall 27% last year, and said that the company would be going through a “period of renewal.” Basically, the tide comes in, but it also goes out. Patents on big-selling medicines expire, but new medicines will come to take their place.

Investors may not be able to view those changes with equanimity. Sales of Bristol’s top sellers will decline significantly or vanish as generic or biosimilar medicines emerge. That includes Eliquis, the blood thinner for stroke prevention that will be one of the first medications subject to price negotiation under the Inflation Reduction Act; Revlimid, the best-selling multiple myeloma medicine that Bristol acquired when it bought Celgene for $74 billion in 2019; and Opdivo, Bristol’s pioneering cancer immunotherapy, which is an $8 billion seller.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： A revolution in caring for preterm infants

leisure time

WSS

Akero's treatment for NASH falls short in cirrhosis study

Lawsuit highlights wrinkle for disputes over surprise medical bills

What the Wegovy shortage looks like for doctors — and for patients

Peter Marks talks Operation Warp Speed for Rare Diseases

Health insurers' Q3 question: how much care are people getting?

Stop Congress from blocking public access to science

hotspot

Wikipedia

explore

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Female surgeons have lower rates of long

How to save PrEP access — and even expand it

Takeaways from AdvaMed, the largest medical devices conference

23andMe had bad news about my health. I wish a person had delivered it

European regulators consider appeal over Amylyx ALS drug

Hepatitis C has a cure — but many Americans still lack access to it

CRISPR base editing slashes cholesterol levels in monkeys

Anesthesiologist group: stop taking Ozempic before surgery

Congress extends some pandemic preparedness programs

hotspot

Peter Marks talks Operation Warp Speed for Rare Diseases

Flu, Covid vaccination rates decline, new survey data show

Experts study whether long Covid risk adds up with each reinfection

Bernie Sanders bashes nonprofit hospitals over their tax breaks

Researchers CRISPR chickens in bid to protect them from bird flu

CRISPR base editing slashes cholesterol levels in monkeys

hotspot

leisure time

entertainment

knowledge